ATE445011T1 - Hemopoietin-rezeptor und dafür kodierende genetische sequenzen - Google Patents

Hemopoietin-rezeptor und dafür kodierende genetische sequenzen

Info

Publication number
ATE445011T1
ATE445011T1 AT96934193T AT96934193T ATE445011T1 AT E445011 T1 ATE445011 T1 AT E445011T1 AT 96934193 T AT96934193 T AT 96934193T AT 96934193 T AT96934193 T AT 96934193T AT E445011 T1 ATE445011 T1 AT E445011T1
Authority
AT
Austria
Prior art keywords
genetic sequences
receptor
sequences coding
hemopoietin receptor
components
Prior art date
Application number
AT96934193T
Other languages
English (en)
Inventor
Tracy Willson
Nicos Nicola
Douglas Hilton
Donald Metcalf
Jian Zhang
Original Assignee
Zenyth Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27157889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE445011(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AUPN6135A external-priority patent/AUPN613595A0/en
Priority claimed from AUPN7276A external-priority patent/AUPN727695A0/en
Priority claimed from AUPO2208A external-priority patent/AUPO220896A0/en
Application filed by Zenyth Operations Pty Ltd filed Critical Zenyth Operations Pty Ltd
Application granted granted Critical
Publication of ATE445011T1 publication Critical patent/ATE445011T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compression, Expansion, Code Conversion, And Decoders (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT96934193T 1995-10-23 1996-10-23 Hemopoietin-rezeptor und dafür kodierende genetische sequenzen ATE445011T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN6135A AUPN613595A0 (en) 1995-10-23 1995-10-23 A novel haemopoietin receptor and genetic sequences encoding same
AUPN7276A AUPN727695A0 (en) 1995-12-22 1995-12-22 A novel haempoietin receptor and genetic sequences encoding same - II
AUPO2208A AUPO220896A0 (en) 1996-09-09 1996-09-09 A novel haemopoietin receptor and genetic sequences encoding same - III
PCT/AU1996/000668 WO1997015663A1 (en) 1995-10-23 1996-10-23 A novel haemopoietin receptor and genetic sequences encoding same

Publications (1)

Publication Number Publication Date
ATE445011T1 true ATE445011T1 (de) 2009-10-15

Family

ID=27157889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934193T ATE445011T1 (de) 1995-10-23 1996-10-23 Hemopoietin-rezeptor und dafür kodierende genetische sequenzen

Country Status (8)

Country Link
EP (1) EP0907730B1 (de)
JP (2) JP4224135B2 (de)
AT (1) ATE445011T1 (de)
AU (1) AU718899C (de)
CA (1) CA2238080C (de)
DE (1) DE69638050D1 (de)
ES (1) ES2334408T3 (de)
WO (1) WO1997015663A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
US7078494B1 (en) 1996-03-01 2006-07-18 Genetics Institute, Llc Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
GB9721961D0 (en) * 1997-10-16 1997-12-17 Glaxo Group Ltd Novel molecules
US6703488B1 (en) * 1998-01-15 2004-03-09 Center For Molecular Medicine And Immunology Antibody/receptor targeting moiety for enhanced delivery of armed ligand
ES2277460T3 (es) * 1998-12-14 2007-07-01 Genetics Institute, Llc Cadena del receptor de la citoquina.
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
EP2325316B8 (de) 1999-06-02 2017-04-19 Chugai Seiyaku Kabushiki Kaisha Neues Hämopoietin Receptorprotein, NR10
DE60025241T2 (de) * 1999-09-27 2007-01-11 Chugai Seiyaku K.K. HäMOPOIETINREZEPTOR-PROTEIN, NR12
CA2480059C (en) 2002-03-22 2015-11-24 Amrad Operations Pty. Ltd. Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13r.alpha.1)
AU2003212102B2 (en) * 2002-03-22 2010-01-14 Zenyth Operations Pty Ltd Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1)
DK2805728T3 (da) 2003-12-23 2020-04-20 Genentech Inc Hidtil ukendte anti-IL13-antistoffer og anvendelser deraf
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
WO2006055638A2 (en) 2004-11-17 2006-05-26 Abgenix, Inc. Fully human monoclonal antibodies to il-13
TW200902555A (en) 2005-01-03 2009-01-16 Hoffmann La Roche Antibodies against IL-13 receptor alpha 1 and uses thereof
CL2007001665A1 (es) 2006-06-08 2008-01-18 Chugai Pharmaceutical Co Ltd Anticuerpo o fragmento del mismo con actividad neutralizante de la proteina nr 10; agente que lo comprende; y su uso para prevenir o tratar una enfermedad inflamatoria.
JP2010507366A (ja) 2006-10-19 2010-03-11 メルク アンド カンパニー インコーポレイテッド インターロイキン−１３受容体α１の抗体アンタゴニスト
WO2008060814A2 (en) 2006-10-19 2008-05-22 Merck & Co., Inc. ANTI-IL-13Rα1 ANTIBODIES AND THEIR USES THEREOF
AU2007319604B2 (en) 2006-10-19 2011-03-24 Csl Limited High affinity antibody antagonists of interleukin-13 receptor alpha 1
MY185647A (en) 2007-12-05 2021-05-27 Chugai Pharmaceutical Co Ltd Therapeutic agent for pruritus
ES2407603T3 (es) 2007-12-15 2013-06-13 F. Hoffmann-La Roche Ag Ensayo de distinción
KR102248581B1 (ko) 2013-07-04 2021-05-06 에프. 호프만-라 로슈 아게 혈청 샘플 중 항-약물 항체를 검출하기 위한 간섭-억제된 면역분석
KR102332302B1 (ko) 2013-09-13 2021-12-01 제넨테크, 인크. 세포주에서 숙주 세포 단백질 및 재조합 폴리펩티드 생성물을 검출 및 정량화하기 위한 조성물 및 방법
SG10201802525QA (en) 2013-09-13 2018-04-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
CA3046489A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
WO2018183932A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor
CN116726361A (zh) 2018-11-19 2023-09-12 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
EP3947457A1 (de) 2019-03-26 2022-02-09 ASLAN Pharmaceuticals Pte Ltd Behandlung mit verwendung von anti-il-13r-antikörper oder bindefragment davon
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
WO2022186772A1 (en) 2021-03-01 2022-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF
WO2022186773A1 (en) 2021-03-01 2022-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION
WO2023048651A1 (en) 2021-09-27 2023-03-30 Aslan Pharmaceuticals Pte Ltd Method for treatment of moderate to severe atoptic dematitis
WO2023048650A1 (en) 2021-09-27 2023-03-30 Aslan Pharmaceuticals Pte Ltd TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF
WO2023075702A1 (en) 2021-10-29 2023-05-04 Aslan Pharmaceuticals Pte Ltd Anti-il-13r antibody formulation
EP4590335A1 (de) 2022-08-26 2025-07-30 ASLAN Pharmaceuticals Pte Ltd Hochkonzentrierte anti-il13r-antikörperformulierung
EP4594352A1 (de) 2022-09-06 2025-08-06 ASLAN Pharmaceuticals Pte Ltd Behandlung von schlafverlust oder schlafstörung bei dermatitispatienten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
CA2197873A1 (en) * 1994-09-05 1996-03-14 Douglas James Hilton A novel haemopoietin receptor
WO1996011213A1 (en) * 1994-10-07 1996-04-18 Amgen Boulder Inc. Dimeric il-4 inhibitors
FR2742156A1 (fr) * 1995-12-06 1997-06-13 Sanofi Sa Polypeptide recepteur de l'il-13

Also Published As

Publication number Publication date
EP0907730A1 (de) 1999-04-14
JPH11514873A (ja) 1999-12-21
AU718899B2 (en) 2000-04-20
CA2238080A1 (en) 1997-05-01
AU7266896A (en) 1997-05-15
AU718899C (en) 2004-01-29
CA2238080C (en) 2012-03-13
JP4224135B2 (ja) 2009-02-12
EP0907730A4 (de) 2001-11-07
EP0907730B1 (de) 2009-10-07
DE69638050D1 (de) 2009-11-19
JP2008029340A (ja) 2008-02-14
ES2334408T3 (es) 2010-03-09
WO1997015663A1 (en) 1997-05-01

Similar Documents

Publication Publication Date Title
ATE445011T1 (de) Hemopoietin-rezeptor und dafür kodierende genetische sequenzen
NO995182D0 (no) Pattedyrcytokinlignende faktor 7
DE69918946D1 (de) Rezeptoren für il-18
PT1015586E (pt) Homologos de ligandos do receptor tirosina-quinase tie
HUP0101022A1 (hu) Kinolinszármazékok gyógyászati alkalmazása
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
DK0760857T5 (da) Receptor for onkostatin M
SE9301755D0 (sv) A method of determining affinity and kinetic properties
DE69428689D1 (de) Hefe zellen so konstruiert, dass sie proteinsurrogate des pheromensystems produzieren und anwendungen dafuer
ID1044B (id) Antibodi terubah dan pembuatannya
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
ATE407208T1 (de) Hemopoietin-rezeptor
ATE252158T1 (de) Nicht-nukleotid verknüpfende reagentien
WO1998011225A3 (en) A novel haemopoietin receptor and genetic sequences encoding same
DE60031576D1 (en) Diagnostisches assay für typ-2-heparin induzierte thrombocytopenie
DE69834643D1 (de) Adipozyten-spezifische protein homologe
TR199701469T1 (xx) �i�man (OB) proteinin etkilerini de�i�tiren bile�imlerin meydana ��kar�lmas� i�in y�ntem.
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
BR9808514A (pt) Proteìnas quiméricas do ligante flt3
ATE332974T1 (de) Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung
PE20399A1 (es) Muteina ob
HUP9901123A2 (hu) ICAM-4 anyagok és módszerek
DE59611293D1 (de) Protein mit dnase-aktivität
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties